Labcorp Holdings Inc. to Issue Quarterly Dividend of $0.72 (NYSE:LH)

Labcorp Holdings Inc. (NYSE:LH) announced a quarterly dividend on Wednesday, January 14th. Stockholders of record on Friday, February 27th will be paid a dividend of 0.72 per share by the medical research company on Thursday, March 12th. This represents a c) dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Friday, February 27th.

Labcorp has a dividend payout ratio of 16.4% indicating that its dividend is sufficiently covered by earnings. Analysts expect Labcorp to earn $17.54 per share next year, which means the company should continue to be able to cover its $2.88 annual dividend with an expected future payout ratio of 16.4%.

Labcorp Price Performance

NYSE LH traded up $7.60 on Wednesday, hitting $261.58. The stock had a trading volume of 843,079 shares, compared to its average volume of 749,716. The company has a market capitalization of $21.68 billion, a price-to-earnings ratio of 25.64, a price-to-earnings-growth ratio of 1.58 and a beta of 1.00. Labcorp has a 52-week low of $209.38 and a 52-week high of $293.72. The firm has a 50-day moving average of $258.98 and a 200-day moving average of $265.86. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.35 and a current ratio of 1.55.

Labcorp (NYSE:LH) last released its quarterly earnings results on Tuesday, October 28th. The medical research company reported $4.18 earnings per share for the quarter, beating the consensus estimate of $4.13 by $0.05. The firm had revenue of $3.56 billion for the quarter, compared to analysts’ expectations of $3.56 billion. Labcorp had a return on equity of 15.85% and a net margin of 6.21%.The company’s revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the firm posted $3.50 EPS. Labcorp has set its FY 2025 guidance at 16.150-16.500 EPS. Equities analysts expect that Labcorp will post 16.01 EPS for the current year.

Labcorp Company Profile

Laboratory Corporation of America Holdings, commonly known as Labcorp (NYSE: LH), is a global life sciences company that provides comprehensive clinical laboratory and drug development services. The company operates a broad network of laboratories, patient service centers and specialty testing sites to deliver diagnostic information and testing solutions that support patient care, clinical decision-making and population health initiatives.

Labcorp’s core businesses encompass clinical laboratory testing and pharmaceutical development services.